Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 3—March 2026

Research Letter

Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017

Victor Naestholt DahlComments to Author , Andreas Arnholdt Pedersen, Michael Høffding Ibsen, Ole Hilberg, Anders Løkke, and Andreas Fløe
Author affiliation: Aarhus University Hospital, Aarhus, Denmark (V.N. Dahl, A. Fløe); Odense University Hospital, Odense, Denmark (A.A. Pedersen); University of Southern Denmark, Odense (A.A. Pedersen, O. Hilberg, A. Løkke); i2minds, Aarhus (M.H. Ibsen); Lillebaelt Hospital, Vejle, Denmark (M.H. Ibsen, O. Hilberg, A. Løkke)

Main Article

Figure 1

Annual average costs before and after extrapulmonary nontuberculous mycobacterial disease diagnosis, Denmark, 2005–2017. A) Total direct healthcare costs; B) employment income; C) total public benefits. Dotted vertical lines indicate year of diagnosis; solid center lines indicate average cost; shaded areas with borders indicate 95% CIs.

Figure 1. Annual average costs before and after extrapulmonary nontuberculous mycobacterial disease diagnosis, Denmark, 2005–2017. A) Total direct healthcare costs; B) employment income; C) total public benefits. Dotted vertical lines indicate year of diagnosis; solid center lines indicate average cost; shaded areas with borders indicate 95% CIs.

Main Article

Page created: February 09, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external